People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cognoptix, Inc. | — | Other Technology | Series A | $17.6M | $349.7M | 2014 |
| Janus Biotherapeutics, Inc. | — | Biotechnology | Seed | $2.3M | $29.0M | 2020 |
Christine De Los Reyes at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christine De Los Reyes on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Reis | 1 | 5 |
| Joseph Baron | 1 | 5 |
| Gunnar Weikert | 1 | 2 |
| Tom Trometer | 1 | 2 |
| Richard Gill | 1 | 2 |
| RICHARD D. GILL | 1 | 2 |
| Gerald D. Cagle | 1 | 2 |
| Werner D. Schaefer | 1 | 1 |
| Steven Bernitz | 1 | 1 |
| Paul Hartung | 1 | 1 |
| Grayson Lipford | 1 | 1 |
| Rainer Hoegg | 1 | 1 |
| Gunnar D. Weikert | 1 | 1 |
| Werner Schaefer | 1 | 1 |
| Tom D. Trometer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.